{
    "nctId": "NCT01273415",
    "briefTitle": "Usefulness of Ki67 Index in Hormone Receptor-positive Breast Cancer",
    "officialTitle": "Usefulness of Ki67 Proliferative Index to Predict Recurrence and Benefit From Adjuvant Chemotherapy in Hormone Receptor (HR)-Positive Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1070,
    "primaryOutcomeMeasure": "to validate Ki67 index to predict recurrence",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* hormone receptor-positive breast cancer patient who received curative surgery from 2004 to 2007 at Samsung Medical Center\n\nExclusion Criteria:\n\n* the patients who received neoadjuvant chemotherapy the patients whose biopsy showed DCIS the patients who were not available immunohistochemical findings the patients who were not available medical record",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}